# Synopsys Inc. (SNPS) – Q1 2025 Financial Forecast

## Revenue and Guidance

 ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2024/Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024/default.aspx#:~:text=,billion%20in%20fiscal%20year%202023))Synopsys delivered record FY2024 results with ~$6.127 B revenue (+15% YoY) and foresees continued demand. For Q1 FY2025 (ending Jan 31, 2025) management guided revenue of **$1.435–$1.465 B** ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2024/Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024/default.aspx#:~:text=Revenue%20%20,%24%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%2098)); we assume the high end of the range (~$1.460 B) given strong AI/EDA tailwinds. For context, Q1 FY2024 revenue was $1.649 B (which included an extra week) ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2024/Synopsys-Posts-Financial-Results-for-First-Quarter-Fiscal-Year-2024/default.aspx#:~:text=fiscal%20year%202024,in%20our%20first%20fiscal%20quarter)), so the comparable base was slightly larger. Our forecast (~$1.460 B) reflects a modest YoY increase on a normalized 13-week basis, in line with management’s double-digit growth outlook.

## Profitability and EPS

 ([news.synopsys.com](https://news.synopsys.com/2025-02-26-Synopsys-Posts-Financial-Results-for-First-Quarter-Fiscal-Year-2025#:~:text=Operating%20income%20%20,104%2C828))GAAP operating income was $251.8 M in Q1 FY2025 (≈17% margin). We forecast GAAP operating income ≈$260 M (≈18% margin), reflecting higher revenue and controlled expenses. Depreciation and amortization were ~$48 M in the quarter ([news.synopsys.com](https://news.synopsys.com/2025-02-26-Synopsys-Posts-Financial-Results-for-First-Quarter-Fiscal-Year-2025#:~:text=Amortization%20and%20depreciation%20%20,12%2C466)); adding back these non-cash charges yields **EBITDA ≈$340 M** (i.e. ~$260 M OI + ~$48 M D&A + other amortization). Synopsys guided GAAP EPS of **$1.81–$1.95** for Q1 FY2025 ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2024/Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024/default.aspx#:~:text=GAAP%20EPS%20%20,%24%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%2014.96)), and actual diluted EPS was $1.89 ([news.synopsys.com](https://news.synopsys.com/2025-02-26-Synopsys-Posts-Financial-Results-for-First-Quarter-Fiscal-Year-2025#:~:text=GAAP%20Results%20On%20a%20U,quarter%20of%20fiscal%20year%202024)). We assume GAAP EPS near the top of this range (~$1.95), implying GAAP net income ≈$310 M (with ~156 M diluted shares). (Non-GAAP EPS beat was stronger, but we base our projections on GAAP results for consistency with these metrics.)

## Cash Flow

 ([news.synopsys.com](https://news.synopsys.com/2025-02-26-Synopsys-Posts-Financial-Results-for-First-Quarter-Fiscal-Year-2025#:~:text=Deferred%20revenue%20%20,%2887%2C790))Operating cash flow was a net **–$67.455 M** in Q1 FY2025, driven by working capital investments. Capital expenditures were ~$40.715 M ([news.synopsys.com](https://news.synopsys.com/2025-02-26-Synopsys-Posts-Financial-Results-for-First-Quarter-Fiscal-Year-2025#:~:text=Purchases%20of%20property%20and%20equipment%2C,%2840%2C391)). These imply free cash flow ≈ –$108 M for the quarter. We forecast **Free Cash Flow ≈–$110 M**, reflecting similar operating cash burn and capex as last year’s Q1.

| Company         | Year | Quarter |     Revenue     |    EBITDA    | Operating Income |   Net Income   | Free Cash Flow |  EPS  |
| --------------- | ---- | ------- | --------------- | ------------ | ---------------- | -------------- | -------------- | ----- |
| Synopsys Inc.   | 2025 | 1       | 1,460,000,000   | 340,000,000  | 260,000,000      | 310,000,000    | –110,000,000   | 1.95  |

**Sources:** Synopsys 10-Q/earnings releases (FY2024 results and FY2025 guidance) ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2024/Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024/default.aspx#:~:text=,billion%20in%20fiscal%20year%202023)) ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2024/Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024/default.aspx#:~:text=Revenue%20%20,%24%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%2098)) ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2024/Synopsys-Posts-Financial-Results-for-First-Quarter-Fiscal-Year-2024/default.aspx#:~:text=fiscal%20year%202024,in%20our%20first%20fiscal%20quarter)) ([news.synopsys.com](https://news.synopsys.com/2025-02-26-Synopsys-Posts-Financial-Results-for-First-Quarter-Fiscal-Year-2025#:~:text=Operating%20income%20%20,104%2C828)) ([news.synopsys.com](https://news.synopsys.com/2025-02-26-Synopsys-Posts-Financial-Results-for-First-Quarter-Fiscal-Year-2025#:~:text=Amortization%20and%20depreciation%20%20,12%2C466)) ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2024/Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024/default.aspx#:~:text=GAAP%20EPS%20%20,%24%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%2014.96)) ([news.synopsys.com](https://news.synopsys.com/2025-02-26-Synopsys-Posts-Financial-Results-for-First-Quarter-Fiscal-Year-2025#:~:text=GAAP%20Results%20On%20a%20U,quarter%20of%20fiscal%20year%202024)) ([news.synopsys.com](https://news.synopsys.com/2025-02-26-Synopsys-Posts-Financial-Results-for-First-Quarter-Fiscal-Year-2025#:~:text=Deferred%20revenue%20%20,%2887%2C790)) ([news.synopsys.com](https://news.synopsys.com/2025-02-26-Synopsys-Posts-Financial-Results-for-First-Quarter-Fiscal-Year-2025#:~:text=Purchases%20of%20property%20and%20equipment%2C,%2840%2C391)). These public disclosures form the basis of our projections.